PROCEPT BioRobotics Corporation (PRCT)
NASDAQ: PRCT · Real-Time Price · USD
25.18
+0.11 (0.44%)
Mar 27, 2026, 12:50 PM EDT - Market open
PROCEPT BioRobotics Stock Forecast
Stock Price Forecast
The 9 analysts that cover PROCEPT BioRobotics stock have a consensus rating of "Buy" and an average price target of $35.44, which forecasts a 40.75% increase in the stock price over the next year. The lowest target is $20 and the highest is $62.
Price Target: $35.44 (+40.75%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for PROCEPT BioRobotics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 3 | 3 | 3 | 3 | 3 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 2 | 2 | 2 | 2 | 2 | 3 |
| Sell | 0 | 0 | 0 | 0 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 9 | 9 | 9 | 10 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Baird | Baird | Hold Initiates $30 | Hold | Initiates | $30 | +19.14% | Mar 6, 2026 |
| Truist Securities | Truist Securities | Strong Buy Maintains $47 → $30 | Strong Buy | Maintains | $47 → $30 | +19.14% | Mar 2, 2026 |
| Leerink Partners | Leerink Partners | Buy Maintains $55 → $30 | Buy | Maintains | $55 → $30 | +19.14% | Feb 26, 2026 |
| TD Cowen | TD Cowen | Strong Buy Maintains $50 → $34 | Strong Buy | Maintains | $50 → $34 | +35.03% | Feb 26, 2026 |
| Oppenheimer | Oppenheimer | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Feb 26, 2026 |
Financial Forecast
Revenue This Year
405.46M
from 308.05M
Increased by 31.62%
Revenue Next Year
504.58M
from 405.46M
Increased by 24.45%
EPS This Year
-1.44
from -1.72
EPS Next Year
-0.80
from -1.44
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 429.6M | 546.0M | |||
| Avg | 405.5M | 504.6M | |||
| Low | 378.1M | 454.0M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 39.5% | 34.7% | |||
| Avg | 31.6% | 24.4% | |||
| Low | 22.7% | 12.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -0.55 | 0.36 | |||
| Avg | -1.44 | -0.80 | |||
| Low | -1.65 | -1.26 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.